WCBE_Header_Final_2.png
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Questions About State Issue 2 Remain

dpa.jpeg

The measure on the November statewide ballot known as Issue 2 requires state agencies to pay the same price for drugs as the U.S. Department of Veterans Affairs. But there are many questions about the Drug Price Relief Act. Ohio Public Radio's Karen Kasler reports.

Issue 2 may turn out to be the most expensive ballot issue campaign in Ohio history, topping the $64 million casino effort in 2008. It’s brought forward a huge ad campaign, and it’s one of the most contentious issues in recent years. The two people speaking on the issue are familiar to many political observers in Ohio. Matt Borges is the former chair of the Ohio Republican Party, and is representing Ohio Taxpayers for Lower Drug Prices. He says the Issue 2 will do two things: “Lower people’s drug prices, make sure the state is not paying more than what the VA pays.”

 

And longtime Democratic strategist Dale Butland, former chief of staff to Senator John Glenn, is speaking for Ohioans Against the Deceptive Prescription Ballot Issue. “The idea that this is going to save much, if any, money is preposterous,” Butland said.

 

The “vote yes” side says the state could save $400 million by requiring that the state pay no more for drugs than the federal Department of Veterans Affairs does. 3.7 million Ohioans in Medicaid and other state programs would be directly affected, and the “vote yes” side says taxpayers will save money directly and through a ripple effect throughout the country and the drug industry. The “vote no” side says the state already has deals with drug companies, and that forcing drug companies into this kind of arrangement would actually have a negative impact, restricting access and driving up prices for other drugs. But there’s a line in the long ballot description that’s notable – it would “require state payment of attorney fees and expenses to specific individuals for defense of the law”. Speaking for the “vote no” side, Butland said that’s a blank check to five people on the “vote yes” side, who’ve already filed more than 50 lawsuits nationwide, “and requires taxpayers to pay their legal fees, to pay their attorneys’ fees and without a cap or limit of any kind on the amount of money Ohioans are on the hook for.”

 

Borges said that’s a red herring by the drug companies that back the opposition. “It also says ‘reasonable attorney fees’, and so we’re not talking about some kind of blank check. But here’s the point. They want to talk about anything but meaningful reform that will actually bring drug prices down for Ohioans,” Borges said.
 

And that’s a big part of the argument Borges makes for the issue – that the drug companies supporting the vote no side are protecting their profits, and they’ll spend whatever they have to do it. “If this wouldn’t actually bring prices down in Ohio, which you’re saying it won’t, and it wouldn’t have a ripple effect through the marketplace so people would save money, why would the drug companies have spent $126 million to defeat this issue in California? Why are the drug companies spending $2 million a week to defeat this measure in Ohio?” Borges said.

 

Butland said the money doesn’t sway some who are against the issue, which is similar to one rejected in California last year. “Every major newspaper editorialized against it. So when Matt says, ‘Oh, it only went down because the drug companies spent all this money.’ Did the drug companies buy all the editorial boards, too, Matt? Come on, give me a break,” Butland said.

 

There is a question of whether the 468,000 people in the state’s retirement systems would be covered by Issue 2. Borges says yes, but Butland and others have said no. That’s likely to be litigated if Issue 2 passes. $24 million has been spent on ads so far – with the “vote no” side spending five times more than the “vote yes” group. And campaign filings at the end of June show nearly $16 million has come in to the “vote no” side from the drug industry and $3.6 million has come to the “vote yes” side from the AIDS Foundation, which is run by the chief backer of Issue 2.

The Statehouse News Bureau was founded in 1980 to provide educational, comprehensive coverage of legislation, elections, issues and other activities surrounding the Statehouse to Ohio's public radio and television stations. To this day, the Bureau remains the only broadcast outlet dedicated to in-depth coverage of state government news and topics of statewide interest. The Bureau is funded througheTech Ohio, and is managed by ideastream. The reporters at the Bureau follow the concerns of the citizens and voters of Ohio, as well as the actions of the Governor, the Ohio General Assembly, the Ohio Supreme Court, and other elected officials. We strive to cover statehouse news, government issues, Ohio politics, and concerns of business, culture and the arts with balance and fairness, and work to present diverse voices and points of view from the Statehouse and throughout Ohio. The three award-winning journalists at the bureau have more than 60 combined years of radio and television experience. They can be heard on National Public Radio and are regular contributors to Morning Edition, All Things Considered and Marketplace. Every weekday, the Statehouse News Bureau produces in-depth news reports forOhio's public radio stations. Those stories are also available on this website, either on the front page or in our archives. Weekly, the Statehouse News Bureau produces a television show from our studios in the Statehouse. The State of Ohio is an unique blend of news, interviews, talk and analysis, and is broadcast on Ohio's public television stations. The Statehouse News Bureau also produces special programming throughout the year, including the Governor's annual State of the State address to the Ohio General Assembly and a five-part year-end review.
Related Content